PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Departments of Neuroendocrinology and Neurosurgery Barrow Neurological Institute University of Arizona College of Medicine and Creighton School of Medicine Phoenix Arizona USA.\', \'University of Arizona College of Medicine-Phoenix Phoenix Arizona USA.\', \'Departments of Neurology and Neuro-Oncology Barrow Neurological Institute/Ivy Brain Center at Phoenix St. Joseph\'s Hospital and Medical Center Phoenix Arizona USA.\', \'Division of Endocrinology and Molecular Medicine Medical College of Wisconsin Milwaukee Wisconsin USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/edm2.246
?:doi
?:hasPublicationType
?:journal
  • Endocrinology, diabetes & metabolism
is ?:pmid of
?:pmid
?:pmid
  • 34268454
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34268454>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34268454>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all